PT2289518T - Agente terapêutico para doenças inflamatórias intestinais - Google Patents
Agente terapêutico para doenças inflamatórias intestinaisInfo
- Publication number
- PT2289518T PT2289518T PT97701080T PT09770108T PT2289518T PT 2289518 T PT2289518 T PT 2289518T PT 97701080 T PT97701080 T PT 97701080T PT 09770108 T PT09770108 T PT 09770108T PT 2289518 T PT2289518 T PT 2289518T
- Authority
- PT
- Portugal
- Prior art keywords
- therapeutic agent
- inflammatory bowel
- bowel disease
- disease
- inflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008162640 | 2008-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2289518T true PT2289518T (pt) | 2016-11-18 |
Family
ID=41444464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97701080T PT2289518T (pt) | 2008-06-23 | 2009-06-22 | Agente terapêutico para doenças inflamatórias intestinais |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8394793B2 (pt) |
| EP (1) | EP2289518B1 (pt) |
| JP (1) | JP5527206B2 (pt) |
| KR (1) | KR101639821B1 (pt) |
| CN (1) | CN102065864B (pt) |
| CA (1) | CA2728161C (pt) |
| CY (1) | CY1118390T1 (pt) |
| DK (1) | DK2289518T3 (pt) |
| ES (1) | ES2611483T3 (pt) |
| HR (1) | HRP20170030T1 (pt) |
| HU (1) | HUE032108T2 (pt) |
| LT (1) | LT2289518T (pt) |
| PL (1) | PL2289518T3 (pt) |
| PT (1) | PT2289518T (pt) |
| SI (1) | SI2289518T1 (pt) |
| WO (1) | WO2009157398A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102705198B1 (ko) | 2009-06-26 | 2024-09-11 | 니뽄 신야쿠 가부시키가이샤 | 결정 |
| WO2011024874A1 (ja) * | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | 塩基付加塩 |
| CN104586853A (zh) * | 2014-12-31 | 2015-05-06 | 武汉联程生物科技有限公司 | 一种用于治疗外伤性颅脑创伤的药物组合物及其制备方法 |
| AU2016366073B2 (en) * | 2015-12-02 | 2021-08-26 | Nippon Shinyaku Co., Ltd. | Pharmaceutical composition containing 2-{4-[N-(5,6- diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N- (methylsulfonyl)acetamide |
| CN109563055B (zh) * | 2016-07-29 | 2021-12-24 | 成都苑东生物制药股份有限公司 | 氨基吡嗪类化合物或盐、异构体、其制备方法及用途 |
| JOP20190204A1 (ar) | 2017-03-08 | 2019-09-05 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على سيليكسيباغ |
| TWI801421B (zh) | 2017-09-28 | 2023-05-11 | 日商日本新藥股份有限公司 | 結晶 |
| BR112020008940A2 (pt) | 2017-11-16 | 2020-10-20 | Nippon Shinyaku Co., Ltd. | preparação de liberação controlada |
| JP2021512902A (ja) | 2018-02-07 | 2021-05-20 | メッドシャイン ディスカバリー インコーポレイテッド | プロスタサイクリン受容体アゴニスト |
| CA3154802A1 (en) | 2019-10-23 | 2021-04-29 | Marc Patrik SCHRADER | Pharmaceutical composition comprising selexipag |
| WO2021152060A1 (en) | 2020-01-31 | 2021-08-05 | Actelion Pharmaceuticals Ltd | Controlled release selexipag composition |
| TW202241425A (zh) | 2021-01-29 | 2022-11-01 | 瑞士商艾克泰聯製藥有限公司 | 用於製造二苯基吡𠯤衍生物之程序 |
| TW202239408A (zh) | 2021-01-29 | 2022-10-16 | 瑞士商艾克泰聯製藥有限公司 | 包含二苯基吡𠯤衍生物的醫藥組成物 |
| WO2023131608A1 (en) | 2022-01-04 | 2023-07-13 | Actelion Pharmaceuticals Ltd | Controlled release compositions |
| WO2023214059A1 (en) | 2022-05-06 | 2023-11-09 | Actelion Pharmaceuticals Ltd | Diphenylpyrazine compounds as prodrugs |
| WO2024017964A1 (en) | 2022-07-20 | 2024-01-25 | Actelion Pharmaceuticals Ltd | Injectable pharmaceutical composition comprising a diphenylpyrazine derivative |
| WO2024133620A1 (en) | 2022-12-22 | 2024-06-27 | Actelion Pharmaceuticals Ltd | In vitro dissolution test |
| WO2024194449A1 (en) | 2023-03-23 | 2024-09-26 | Actelion Pharmaceuticals Ltd | Pharmaceutical composition comprising a diphenylpyrazine derivative |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO440696A0 (en) * | 1996-12-30 | 1997-01-23 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| TWI316055B (pt) * | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| US7326716B2 (en) * | 2003-06-06 | 2008-02-05 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| US7101906B2 (en) * | 2004-11-16 | 2006-09-05 | Allergan, Inc. | 2,3,4-substituted cyclopentanones as therapeutic agents |
| DK2246336T3 (da) * | 2008-02-28 | 2020-07-20 | Nippon Shinyaku Co Ltd | Fibroseinhibitor |
-
2009
- 2009-06-22 CN CN2009801246843A patent/CN102065864B/zh active Active
- 2009-06-22 ES ES09770108.0T patent/ES2611483T3/es active Active
- 2009-06-22 WO PCT/JP2009/061287 patent/WO2009157398A1/ja active Application Filing
- 2009-06-22 LT LTEP09770108.0T patent/LT2289518T/lt unknown
- 2009-06-22 DK DK09770108.0T patent/DK2289518T3/en active
- 2009-06-22 HU HUE09770108A patent/HUE032108T2/en unknown
- 2009-06-22 EP EP09770108.0A patent/EP2289518B1/en active Active
- 2009-06-22 CA CA2728161A patent/CA2728161C/en active Active
- 2009-06-22 PT PT97701080T patent/PT2289518T/pt unknown
- 2009-06-22 PL PL09770108T patent/PL2289518T3/pl unknown
- 2009-06-22 SI SI200931585A patent/SI2289518T1/sl unknown
- 2009-06-22 US US13/000,791 patent/US8394793B2/en active Active
- 2009-06-22 KR KR1020107028238A patent/KR101639821B1/ko active IP Right Grant
- 2009-06-22 JP JP2010517993A patent/JP5527206B2/ja active Active
-
2016
- 2016-12-23 CY CY20161101341T patent/CY1118390T1/el unknown
-
2017
- 2017-01-10 HR HRP20170030TT patent/HRP20170030T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2611483T3 (es) | 2017-05-09 |
| LT2289518T (lt) | 2017-01-10 |
| CA2728161C (en) | 2017-06-06 |
| HUE032108T2 (en) | 2017-08-28 |
| CY1118390T1 (el) | 2017-06-28 |
| CA2728161A1 (en) | 2009-12-30 |
| JPWO2009157398A1 (ja) | 2011-12-15 |
| EP2289518A4 (en) | 2012-04-11 |
| EP2289518B1 (en) | 2016-11-02 |
| HRP20170030T1 (hr) | 2017-03-24 |
| JP5527206B2 (ja) | 2014-06-18 |
| CN102065864B (zh) | 2012-11-21 |
| US8394793B2 (en) | 2013-03-12 |
| KR20110036537A (ko) | 2011-04-07 |
| DK2289518T3 (en) | 2017-01-16 |
| CN102065864A (zh) | 2011-05-18 |
| US20110118254A1 (en) | 2011-05-19 |
| PL2289518T3 (pl) | 2017-03-31 |
| WO2009157398A1 (ja) | 2009-12-30 |
| SI2289518T1 (sl) | 2017-02-28 |
| KR101639821B1 (ko) | 2016-07-14 |
| EP2289518A1 (en) | 2011-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2289518A4 (en) | THERAPEUTIC AGENT FOR INFLAMMATORY ABDOMINAL DISEASE | |
| IL207892A0 (en) | Agent for treating disease | |
| HK1151533A1 (zh) | 種治療疾病的試劑 | |
| ZA201007215B (en) | Agent for treating disease | |
| EP2119444A4 (en) | THERAPEUTIC AGENT FOR PAIN | |
| PT2252148T (pt) | Métodos de tratamento da síndrome do intestino irritável | |
| HRP20190045T1 (hr) | Metode i sastavi za liječenje upalne bolesti crijeva | |
| EP2397139A4 (en) | AGENTS AGAINST NEURODEGENERATIVE DISEASES | |
| PT2280717T (pt) | Agente terapêutico para doenças anaeróbias | |
| HK1141708A1 (en) | Agent for treatment of pulmonary disease | |
| GB0700972D0 (en) | Treatment of inflammatory disease | |
| EP2304437A4 (en) | DIAGNOSTIC AID SPECIFIC TO A DISEASE | |
| GB0720976D0 (en) | Treatment of inflammatory disease | |
| EP2044957A4 (en) | TREATMENT AGENT FOR INFLAMMATORY BOWEL DISEASE | |
| EP2601954A4 (en) | THERAPEUTIC FOR DISEASES | |
| GB0900484D0 (en) | Therapeutic agent | |
| EP2543388A4 (en) | MEDICINAL PRODUCT FOR INFLAMMATORY ENDURANCE | |
| EP2127658A4 (en) | THERAPEUTIC AGENT AGAINST MORBUS MENIERE | |
| EP2140876A4 (en) | THERAPEUTIC AGENT COMPRISING VASOHIBINE | |
| EP2210878A4 (en) | THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES | |
| EP2500029A4 (en) | THERAPEUTIC AGENT FOR DISEASES OF THE STOMACH DARM TRAKTS | |
| EP2324827A4 (en) | THERAPEUTIC ACTIVE FOR ANCA-ASSOCIATED VASCULITIDES | |
| GB0915348D0 (en) | Efficient therapy for subjects with inflammatory bowel diseases | |
| GB0817810D0 (en) | Agent for treating disease | |
| GB0817809D0 (en) | Agent for treating disease |